In the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) cohort, primarily comprising incident hemodialysis patients of African American descent, elevated serum FGF-23 levels were associated with a higher prevalence of coronary artery calcification. The gene discussed is FGF23; the disease is stage 5 chronic kidney disease.